Cytokinetics | CYTK - Assets


Cytokinetics reported $1.44B in Assets for its fiscal quarter ending in September of 2025.





Assets Change Date
Acadia Pharmaceuticals USD 1.33B 105.22M Sep/2025
Amgen USD 90.14B 2.24B Sep/2025
Bayer EUR 104.21B 1.03B Sep/2025
Biogen USD 29.21B 877.3M Sep/2025
Bristol-Myers Squibb USD 96.89B 2.21B Sep/2025
Cytokinetics USD 1.44B 210.92M Sep/2025
Eisai JPY 1.44T 28.38B Sep/2025
Eli Lilly USD 114.94B 14.01B Sep/2025
Exelixis USD 2.82B 145.47M Sep/2025
Geron USD 567.38M 12.18M Sep/2025
Halozyme Therapeutics USD 2.22B 167.33M Sep/2025
Ionis Pharmaceuticals USD 3.03B 47.96M Sep/2025
Ligand Pharmaceuticals USD 1.48B 528.17M Sep/2025
Merck USD 129.55B 12.02B Sep/2025
Novartis USD 107.29B 2.89B Sep/2025
Pfizer USD 208.73B 2.64B Sep/2025
Regeneron Pharmaceuticals USD 40.56B 389.3M Dec/2025
Roche Holding CHF 100.7B 5.94B Dec/2025
Sanofi EUR 126.81B 2.99B Dec/2025